Back to 
Empower Advisory Group, LLC
Empower Advisory Group, LLC
AMRX
Showing 0 of 2 quarters
Position history for Empower Advisory Group, LLC's holdings in AMNEAL PHARMACEUTICALS INC
No. Empower Advisory Group exited its AMRX (Amneal Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 22,391 shares worth $135,913. Empower Advisory Group first reported AMRX in Q4 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.